Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Factor II (Prothrombin) Activity

Coagulation

Factor II activityFIIProthrombin activity

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the functional activity of factor II, also called prothrombin, a key protein your body uses to form stable blood clots. It assesses how well factor II is working in your plasma, rather than just how much of the protein is present. Activity testing reflects the combined effect of production by the liver, availability of vitamin K, and the presence of any inhibitors or interfering medicines.

Clinicians use factor II activity testing to help investigate unusual bleeding or easy bruising, to clarify the cause of a prolonged clotting screen, or to evaluate for rare inherited or acquired deficiencies. It is often interpreted alongside tests such as PT/INR, aPTT, and sometimes mixing studies to give a fuller picture of your clotting system.

Why it matters

Too little factor II activity can lead to bleeding because your blood cannot form a firm clot. Low activity may result from decreased production in liver disease, lack of vitamin K, certain medications, or an inhibitor that interferes with factor II function. Rarely, people inherit a factor II deficiency. Measuring activity helps your care team pinpoint the cause and choose the right treatment.

Doctors may order this test when you have unexplained bleeding, abnormal screening tests of clotting, suspected vitamin K deficiency, or to evaluate the effect of medications that influence vitamin K dependent factors. It can also assist in distinguishing between a true deficiency and the presence of an inhibitor that blocks factor function.

Understanding your results

Your clinician will interpret your factor II activity together with your history, examination, and other lab results. If activity is lower than expected, your team may look for reversible causes such as vitamin K deficiency or medication effects, check liver health, or perform additional studies like mixing tests to see if an inhibitor is present. If an inherited deficiency is suspected, specialized testing or referral to a hematology specialist may be recommended.

If activity appears appropriate for your situation, it suggests that prothrombin function is adequate and that any bleeding symptoms may be due to other factors. Regardless of the value, do not start or stop medications without medical advice. If you are pregnant, recently had surgery, or have a new illness, tell your clinician, as these contexts can change how results are interpreted and may guide follow-up testing.

Reference ranges

0.51.5 U/mL
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Factor II (Prothrombin) Activity

  • Blood thinners and anticoagulants

    Vitamin K antagonists and some direct oral anticoagulants can lower measured factor II activity or interfere with clot-based assays. Always list all prescription and over-the-counter medicines and supplements.

  • Vitamin K status

    Factor II is a vitamin K dependent protein. Poor dietary intake, malabsorption, antibiotic use, or bile acid disorders can reduce vitamin K and lower factor II activity.

  • Liver function

    The liver makes factor II. Hepatitis, cirrhosis, or acute liver injury can reduce production, leading to decreased activity in plasma-based assays.

  • Sample handling and timing

    Improper tube fill, delayed processing, or extreme temperatures can affect clotting assays. Fasting is not required, but timely, well-mixed citrate samples are important for reliable results.

  • Inhibitors and lupus anticoagulant

    Specific inhibitors to factor II and nonspecific inhibitors like lupus anticoagulant can interfere with one-stage clotting assays. Mixing studies or alternative methods may be needed.

  • Physiologic and special populations

    Pregnancy, the newborn period, acute illness, or recent transfusion can alter factor measurements and may require cautious interpretation by your clinician.

2026

References

  1. McGill University Health Centre. (2015, March 01). Factor II 1:40 (Task CD 701456). Laboratory reference ranges.
  2. International Council for Standardization in Haematology. (2021). Guidelines for laboratory measurement of coagulation factor activity and inhibitors using one-stage clotting and chromogenic assays.
  3. Kitchens, C. S., Kessler, C. M., & Konkle, B. A. (2013). Consultative Hemostasis and Thrombosis (3rd ed.). Elsevier.